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Abstract. In recent years the role of epidemic models in informing public
health policies has progressively grown. Models have become increas-
ingly realistic and more complex, requiring the use of multiple data
sources to estimate all quantities of interest. This review summarises
the different types of stochastic epidemic models that use evidence syn-
thesis and highlights current challenges.
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1. BACKGROUND
Epidemic models have become increasingly central to public health decision
making, providing quantitative support to the efficient planning of health-care
resources, the determination of optimal control strategies and the assessment of
interventions to interrupt disease transmission. All of these require knowledge on
hidden aspects of epidemics, such as current disease prevalence, severity, incidence
and transmission, which can only been inferred through modelling. As a conse-
quence of this crucial role of models, the methodologies underpinning epidemic
modelling has come under increasing scrutiny. This has lead to more frequent
adoption of rigorous approaches to linking models to data [28], increasing model
complexity and the need to use rich data arrays to guarantee reliable estimation.
The result has been a recent proliferation of models incorporating data from
multiple sources [e.g. 3, 32].
In an attempt to summarise and critically review this literature, we will charac-
terise models using a common construct. Most epidemic models can be expressed
in terms of a general state-space framework:
Xt ∼ pφ (·|xt−1) (state equation)(1.1)
Yt ∼ p(φ,η) (·|xt) (observation equation)(1.2)
where t = 1, . . . , T and the p(·|·) are appropriately chosen probability density
functions [11]. The state equation (1.1) governs the evolution of an epidemic sys-
tem, represented by a state vectorXt, characterised by a vector-valued parameter
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φ. Equation 1.2 relates the underlying epidemic system to relevant data Yt. These
data are typically imperfect observations associated with Xt, constrained by the
limitations of surveillance schemes and subject to a nuisance parameter, η. State
vectors typically consist of all latent quantities that change over time (usually
probabilistically), and φ governs their temporal development. In some cases, the
state vector is simply a function of φ. More commonly, epidemic models are com-
partmental, partitioning a population according to, for example, infection status.
The numbers of individuals in each model compartment is included in the state
vector, as is any quantity describing model dynamics that evolves over time, e.g.
infection intensity [7] or the transmission potential [48]).
The focus of the statistical analysis could be to estimate unobserved system
states X1:T either sequentially (filtering) or retrospectively (smoothing), and/or
to make inference about components of θ = (φ,η) that have some crucial inter-
pretation. These parameter components might measure some headline statistic
for the epidemic, such as the epidemic’s reproductive number R0, the average
number of secondary infections caused by a single primary infection in a wholly
susceptible population, or the effect of an intervention. This inference, ideally,
would be based on direct observations on the epidemic system, i.e.
(1.3) Yt = Xt + η
T Y,t, where Y,t ∼ N (0, I) .
However (1.3) implies observation of, for instance, new infections as they occur,
which, especially in large populations, is rarely feasible. More realistically, data
are indirectly related to the quantities of interest and inference becomes possible
only through the integration of data from multiple sources, allowing, for exam-
ple, the evaluation of biases, separation of signal from noise or the interpolation
of missing data. Thus, given θ, Yt is a collection of N independent datapoints
(y1t , . . . ,y
N
t ).
Evidence does not just come in the form of data. There are also modelling
assumptions that underlie the parametric forms of pφ(·) and p(φ,η)(·), based on
relevant literature, expert opinion and/or collateral data not included in the mod-
elling process. In particular, pragmatic choices might need to be made over which
parameter components can realistically be estimated by the available data, and
which components it is prudent to assume to be known from literature. Synthe-
sis of this kind of a priori evidence can be formalised by adopting a Bayesian
framework centered on the posterior distribution
(1.4) p (θ,x1:T |y1:T ) ∝ p (y1:T |x1:T ,θ) p (x1:T |θ) p (θ) ,
where p(θ), the prior distribution for θ, encodes all that is known of θ from
sources external to the present study. The posterior distribution represents a
natural synthesis of this additional external information with y1:T .
In this paper, we shall provide an overview of evidence syntheses in stochastic
epidemic modelling where multiple types of data are explicitly used in an inte-
grated analysis. In Section 2 we will focus on non-mechanistic statistical models
for epidemic data. Initially these models will be static, and the aim of the analysis
is to estimate the current state of an epidemic. This set-up will then be extended
by adding a time dimension, initially to estimate time-varying incidence. In Sec-
tion 3 we consider how multiple sources of data are used for inference in mechanis-
tic models for disease transmission, where the dynamics governing transmission
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are assumed to be deterministic (i.e. var (Xt|xt−1) = 0,∀t), so that stochasticity
is only provided by the observational component. Section 3.4 reviews evidence
syntheses in epidemic models with stochastic dynamics (i.e. var (Xt|xt−1) 6= 0).
The paper concludes with a discussion, identifying some ongoing and future chal-
lenges in the use of multiple datasets in stochastic epidemic modelling.
2. NON-MECHANISTIC EPIDEMIC MODELLING
2.1 Static Models
Often estimation of the state of an epidemic at a particular point in time
is of interest. In such examples, static or “snapshot” models are used, and the
temporal evolution in Equations 1.1 and 1.2 is not relevant:
X ∼ pφ (·)
Y ∼ pθ (·|X)
In many cases, X will be a deterministic function of φ, i.e.X ≡X(φ), or can be
integrated out of the analysis entirely if estimation of φ is the focus. Therefore,
for notational ease, we shall write θ = (φ,η,X).
As in Section 1, come in the form ofN independent components y = (y1, . . . ,yN ),
where each yn, n ∈ 1, . . . , N may be multivariate. The aim of the evidence syn-
thesis is to estimate a set of K basic parameters θ = (θ1, . . . , θK) from the
complete array of information. Each dataset yn is assumed to inform a function
ψn = ψn(θ) of the basic parameters, where ψn is denoted a functional parameter.
If ψn(θ) ≡ θk, the data yn are said to directly inform θk, whereas if the function
is more complex and/or a function of multiple components of θ, yn indirectly
informs one or more parameters. Denote by ψ the collection of functional pa-
rameters (ψ1, . . . ψN ). Assuming conditional independence of each dataset, the
likelihood is then
L(θ;y) =
N∏
n=1
Ln(ψn(θ);y
n)
where each Ln(ψn(θ);y
n) is the contribution of yn to the basic parameters. This
likelihood is either maximised, in a frequentist setting, or, in the Bayesian set-
ting we consider here, a posterior distribution is obtained (equation (1.4)), sum-
marising all information, both direct and indirect (as well as prior) on the basic
parameters.
Such an evidence synthesis model can be represented as a directed acyclic
graph (DAG) that encodes the conditional independence assumptions [29]. In
the example of Figure 1, each basic parameter θk ∈ θ, denoted by double circles,
is a founder node of the DAG, i.e. using family relationships to describe the rela-
tionships between nodes in the DAG, it has no parents nodes, only descendants.
Functional parameters ψn ∈ ψ (single circles) are children of the basic parameters
of which they are functions, with the dashed arrows denoting the (determinis-
tic) functional relationship. By contrast, a solid arrow denotes a distributional
(stochastic) relationship between nodes. Squares denote observed quantities yn.
In a more complex hierarchical model with multiple levels, consequential nodes
internal to the DAG may be either deterministically or stochastically related to
their ancestors or descendants. Repetition over variables is represented by ‘plates’,
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θkθ1 . . . θK. . .
ψn
yn
n ∈ 1 . . . N
Fig 1. Directed Acyclic Graph of a model with basic parameters, functional parameters and data.
rounded rectangles surrounding the repeated nodes, as for example the repetition
of each yn, n ∈ 1 . . . N informing a different functional parameter ψn in the figure.
Evidence synthesis methods of this type in the context of medical and health-
care data were introduced in a synthesis of HIV prevalence data from different
groups by [2] and reviewed in [3]. These have inspired a proliferation of com-
prehensive evidence syntheses particularly for static models of infectious disease,
a prime example of which is the United Kingdom (UK) annual HIV prevalence
(and, in particular, undiagnosed prevalence) estimates (https://www.gov.uk/
government/statistics/hiv-in-the-united-kingdom). These are produced
from multiple routine HIV surveillance datasets combined with contemporaneous
cross-sectional survey data. Figure 2(a) presents a DAG of this general approach,
summarised in [17]. Here the ψ are expressed as a function of basic parame-
ters: ρg, the proportion of a population in a particular risk group g for HIV; pig,
the proportion of group g infected; and δg, the proportion of infections in group
g that are detected (diagnosed). This work has spread beyond the UK to the
Netherlands [13] and Poland [45].
Outside of HIV, similar analytical principles have been used to monitor the
Hepatitis C virus (HCV) [55, 18]. In common with the HIV models, the prevalence
of HCV in hard-to-reach populations, such as people who inject drugs (PWID),
requires simultaneous estimation of the proportion of the population who are
PWID as well as HCV prevalence [27, 40, 34]. The estimation of influenza sever-
ity, measured by attack rates (i.e. cumulative incidence) and case-severity risks
(probabilities of severe health events, such as hospitalisation, given infection) has
also been approached through evidence syntheses [38, 39, 49, 33]. Moreover, the
healthcare burden from campylobacter infection has been similarly studied [4].
Although the motivation behind evidence synthesis is to frame all the available
information on the state of an epidemic within a single integrated analysis, for
a number of reasons, including computational efficiency or uncertainty in model
structure, it may be convenient to break the problem into smaller components.
Whereas [40] fit a model for HCV prevalence in two stages, [41] present a synthe-
sis of many evidence syntheses, in an attempt to characterise the link between
chlamydia infection and long-term damage to reproductive health. In [39] three
waves of A/H1N1pdm influenza infection in England are modelled in near isola-
tion, with only weak correlation of the numbers infected in each wave. Although
this ‘modular’ approach is often reasonable and convenient, merging the resulting
sub-models into a single analysis is non-trivial (see Section 4).
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Fig 2. (a) DAG of a HIV prevalence model with basic parameters θ = (ρg, pig, δg). (b) Linking
a series of snapshot HIV prevalence models at multiple time points t, to estimate HIV incidence
in a ODE-driven compartmental model. Time t data yt = (y
1
t , y
2
t , . . . , y
n
t ) are augmented byby
demographic and other transition rate data zt = (y
n+1
t , . . . , y
N
t ). The parameters from (a), both
basic and functional, are now encapsulated within θt.
2.2 Dynamic Models
In most cases, interest will lie in estimating the evolution of an epidemic, and
in the rates of infection, in particular. One way to uncover this temporal variation
is by linking snapshot analyses. At time t, data are distributed
Yt ∼ pθ (·|Xt) ,
and are linked over time via some smoothing of the state variables Xt. This
linkage is achieved for the HIV prevalence example (see Figure 2(a)) by impos-
ing a multi-state model [37], partitioning the population into four disease states
Xt. This continuous-time model uses a system of ordinary differential equations
(ODEs) to describe model dynamics. Time-varying transition rates, including
HIV incidence, become the piecewise-constant basic parameters φ = {λg(t)}, the
identifiability of which is feasible through the inclusion of additional demographic
data zt.
A further example of snapshot-type evidence synthesis over time is in toxo-
plasmosis [60] where temporal smoothing is through random walk distributions
placed on the log-incidence Xt:
log (Xt) ∼ log (Xt−1) + φT X,t.
Using more routine time series type data, a similar random walk is used to smooth
pertussis incidence in [35]. Random walks are also used in a study of swine in-
fluenza prevalence in abattoirs [53], where, routine virological (swabbing to test
for viral presence) and serological (testing of blood samples for an immunologi-
cal response) data are used to distinguish recent from longer-standing infections.
Here, Xt is composed of the proportion positive in the two data streams.
Back-calculation represents an approach to estimating incidence when the
available data are time series counts of clinical endpoints. The classic back-
calculation example is the estimation of HIV incidence from AIDS diagnoses
[12], based on the convolution equation:
(2.1) µ(t) =
∫ t
0
h(s)f(t− s)ds.
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Here µ(t) is the time-varying rate at which diagnoses occur, which is expressed
in terms of an assumed known distribution function for the incubation period
f(·) and the rate h(·) at which new infections occur. Versions of (2.1) that use
additional sources of information have been developed [15] and extended to tackle
the challenges posed by therapeutical advances and developments in HIV surveil-
lance, augmenting AIDS diagnoses with HIV diagnoses [14]. Multi-state versions
have been proposed [1], with states defined by the levels of markers of HIV pro-
gression (e.g. CD4 cell counts), characterising the diagnosis process as the result
of disease progression and the propensity to test. HIV diagnosis data have been
further augmented in [54] by observations on CD4 counts around diagnosis, to es-
timate the diagnosis process and the number of undiagnosed infections by disease
state. This work is extended in [7], using random-walks to model the evolution
of incidence and diagnosis rates over time [61]. Back-calculations of this type can
be framed in terms of a state-space model by letting the state vector Xt include
incidence ht, diagnosis rates and state occupancies. The parameter θ is composed
of initial conditions and random-walk variances. If the model is evaluated at dis-
crete intervals, with no observation error assumed, then diagnoses are Poisson
distributed and the CD4 data follow a multinomial distribution, falling into the
following formulation:
Xt = pφ (·|Xt−1)
Yt = gθ (Xt)
The observation model becomes non-trivial in the presence of overdispersion. Ad-
ditional data from recent infection testing algorithms (RITA) to identify recent
infections amongst newly diagnosed individuals are becoming increasingly avail-
able [52] and preliminary attempts to integrate this type of data into a more
traditional back-calculation have been made [64]. Inversely, in a study to deter-
mine the contribution of early HIV infections towards transmission, [58] fitted a
back-calculation model in a first stage of analysis, before using HIV genetic se-
quence data, alongside other epidemiological information, to estimate the timing
of HIV transmission.
3. EVIDENCE SYNTHESIS IN MECHANISTIC TRANSMISSION MODELS
The classic approach to tracking the spread of an epidemic is through compart-
mental models that partition the population into susceptible/infected/removed
(SIR) categories [5] - or one of many similar variants. In the epidemic modelling
literature these models are labelled as mechanistic transmission models. They
differ from the multi-state models described earlier due to the explicit modelling
of the transmission mechanisms, where rates of infection are a function of the
prevalent number of infected and infectious individuals.
The dynamics of such models unfold according to a system of ordinary or
stochastic differential equations (or their discrete-time difference approximations).
Initially, focus will be on models for which there is a deterministic state relation,
but the epidemic is imperfectly observed. These can be expressed as:
Xt = fφ (Xt−1)
Yt ∼ pθ (·|Xt) .
(3.1)
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where fφ(·) indicates a deterministic functional relationship, characterised by pa-
rameter φ and Xt represents the number of people within each stage of the SIR-
type model. Typically, φ will include rates of transition between model states,
relative rates of contact between different population strata and the transmis-
sion potential. These movements between model states are unobserved, and, as
in Section 2.2, the use of multiple data sources becomes necessary for identifiabil-
ity. Several examples exist, where epidemic surveillance data are synthesised with:
serological data; demographic, administrative or environmental data; and/or phy-
logenetic data.
3.1 Surveillance and Serological Data
Serological data identify the proportion of the population in the susceptible
state. Typically these data are binomially distributed with the probability pa-
rameter at time t given by
P(seropositive at time t) = 1− St/N
where St is the number of susceptibles among a population of size N . As an
epidemic unfolds, the increase in the seropositivity of samples should mirror the
levels of cumulative incidence.
The work in [9] highlights the important role played by serology data in uncov-
ering an epidemic’s dynamics. Here, serological data are used to provide informa-
tion on the scale of infection. Due to the presence of asymptomatic infection, this
scale could not be derived while the epidemic is ongoing from data on general
practice (GP) consultations for influenza-like illness and associated virological
swabbing alone. A similar approach is applied to data from Israel [63], and [20]
extend this work to look at the changes in the immunity profile of a popula-
tion and the fluctuating transmissibility of the virus between temporally distinct
waves of infection. Given the importance of serological data, [56] develops the
approach further in application to Dutch A/H1N1pdm influenza, taking into ac-
count the sensitivity and specificity of the serological testing process. The authors
model actual titre values, giving a probabilistic interpretation of immunity.
Outside of the 2009 pandemic, [6] model individual ‘flu seasons on the basis
of primary care data (consultations plus swab positivity and, where they exist,
serological data), whilst also making some allowance for the uncertainty in the
contact matrices that are used as a central fulcrum of the transmission model.
3.2 Surveillance and Demographic, Administrative or Environmental Data
An example of joint modelling of surveillance and demographic data is in [37],
where the model in Figure 2(b) is extended to include a component of disease
transmission utilising information Zt = zt on ageing, migration and mortality.
This is a rare example where such data contributes to the likelihood. More com-
monly demographic data are used as explanatory variables. Here, assume that
the observation model is defined for data Yt = yt, but we also have explanatory
data Zt. Then the system equation in (3.1) is replaced by
Xt = fφ (Xt−1,Zt) .
These explanatory data can come in many forms: [6] and [48] use vaccination data
to inform transition rates out of a susceptible state; [10] use commuting data
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to describe inter-region transmission; [63] relate transmission of A/H1N1pdm
influenza in Israel to an index of ‘mean absolute humidity’. One particularly
successful example of this type of data has been the use of air traffic data in the
GLEAM system for the global tracking (and prediction) of a pandemic influenza
outbreak [e.g. 57]. Here, the global spread of pandemic outbreaks is identified
by short time series of virologically-confirmed A/H1N1pdm influenza cases, a
spread that is assumed to occur along the lines of a network formed on the basis
of established flight paths.
3.3 Surveillance and Phylogenetic Data
One synthesis of two very different types of information is evident where ge-
netic analyses of pathogen genomes are used to provide or augment inference on
the spread of the pathogen through a population. Gene genealogies can be recon-
structed from gene sequence data to produce phylogenetic trees (or phylogenies).
The branching points of the phylogenies can then be used to inform a simple
coalescent model, the rate of coalescence of which can be linked to the number
of infective individuals within the population.
Initially, phylogenies were used to estimate epidemic growth rates and epidemic
emergence times using simple, non-mechanistic models under strict assumptions
[43]. However, in [42] and [59] there is a body of work emerging to link the
phylogenies into mechanistic transmission models, with examples in HCV and
HIV infection respectively. [19] develop a methodology for phylodynamic models,
showing that an SIR model can be identifiable on the basis of genomic data
alone, without augmenting using surveillance data. [43], however, note that the
use of phylogenetic information is of particular utility in the case where the
surveillance counts are highly noisy or only weakly informative, and their work
in links phylogenies to a continuous-time, continuous-space stochastic epidemic
model informed by both epidemiological surveillance data and phylogenetic data.
3.4 Stochastic epidemic models
In many cases, the deterministic dynamics are not sufficient. When numbers
infected are sufficiently small that stochastic fluctuations in transmission can
significantly impact on the future epidemic trajectory, deterministic epidemics
can lead to over-optimistic forecasts, and can exclude the non-zero possibility of
epidemic extinction when the epidemic reproductive number, R is > 1. Similarly,
when the epidemic unfolds in the presence of environmental or other external
factors not typically captured by the transmission model, stochasticity in the
temporal evolution of parameter values can have a significant impact on the
pattern and timing of infections. In either case, these models require the full
state-space specification of equations (1.1) and (1.2).
In the case of demographic stochasticity, chain-binomial [30], chain multinomial
[61] or chain negative binomial [23] models may be used. It is, however, the second
context of unexplained variablility that is more prevalent in the literature. In
particular, the transmission potential β(t) is commonly modelled as a stochastic
process. [21, 62] cast β(t) as Wiener and Gaussian processes respectively, whereas
[48] impose a random effects model on β(t).
Though the motivation for the use of multiple sources of data in stochastic
epidemic modelling is frequently no different to the deterministic case, there are
few examples of their use in the literature. Using traditional forms of influenza
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surveillance, [48] constitutes a rare example, where laboratory-confirmed data on
‘mild’ cases are combined with data on (nested) admissions to hospitals and to
ICUs. Both types of stochasticity are in effect also, as the model is in discrete
time and assumes chain binomial transmission, whilst the force of infection arises
as the result of a random effects model. Stochastic epidemic models have been
used in analyses of the type discussed in Section 3.3, initially through the mod-
elling study of [43], who propose an SIR model allowing for both seasonality and
environmental noise in transmission. This work is extended by [44] through a
case study of competing viral subtypes of A/H3N2 influenza, whose transmis-
sion model incorporates demographic (chain-multinomial) stochasticity, fitting
the overall phylodynamic model using approximate Bayesian methods.
4. DISCUSSION
The recent increase in the number of evidence syntheses, mostly Bayesian, to
estimate latent characteristics of epidemics is testimony of the crucial role of data
from multiple sources. This role has been comprehensively explored in other re-
views [3, 17], but include the ability to: identify and estimate key quantities that
are not directly observed; introduce and formally quantify expert judgement in
the form of prior distributions; readily account for and estimate known biases
in observational data through the introduction of bias parameters with carefully
chosen priors; and the minimisation of selection bias through the use of all avail-
able relevant data, both direct and indirect.
However, although the adoption of evidence synthesis methods signal an ability
to fit models of increasing realism and complexity, some general challenges remain
[16] and are the subject of active research.
4.1 Model building
As briefly discussed in Section 2.1, it may be convenient to divide a complex
model into smaller, more manageable sub-models. Reasons include computational
tractability as well as the need to explore alternative model formulations during
a model development phase. However, summarising the results of each sub-model
into a second-stage “full” model in a manner that retains the feedback from differ-
ent data sources to common parameters is not straightforward. Recent work that
allows for principled inference from a fully joint model given posterior samples
from each sub-model has been proposed [24]. The application of this “Markov
melding” approach to evidence syntheses in the stochastic epidemic field has the
potential to address some of the computational challenges that arise from complex
stochastic models.
4.2 Model criticism
In any model-based analysis, critical assessment is important, but there are
some particular aspects that arise in multiple source analyses in the context
of epidemic modelling. Since so many epidemic characteristics are not observable
directly, the question of which parameters are identifiable (partially or fully) from
the available data sources is an active area of research [26]. How to determine
algebraically, ahead of any inference, which parameters are potentially identifiable
in a complex dynamic system has been explored recently in the systems biology
field [e.g. 25]: such methods have the potential to be adapted to transmission
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models. An alternative is to consider adapting value-of-information methods [e.g.
36] to the case of evaluating gains in precision in parameter estimates resulting
from collecting or incorporating further evidence.
In contrast to weak identifiability issues, multiple data sources may inform
the same parameter, leading to the potential for conflicting evidence [16]. Such
potential represents a further motivation for modular model-building, uncovering
the influence of each additional data source. As already discussed however, such
modular approaches are computationally intensive, so the use of cross-validatory
conflict diagnostics, both at the model-building and model-assessment stages,
requires adaptation to enable timely inference.
Once conflicts have been detected and measured, they require resolution. Typ-
ically, conflicts arise as a result of unaccounted bias and/or naive interpretation
of what the data represent. Bias modelling approaches to resolve conflict are typ-
ically related to ideas of how best to weight different sources of evidence in a
synthesis [16], which is still an open question. While in a frequentist framework
there are well-established methods to account for selection biases in the types
of observational data usually included in epidemic evidence syntheses, Bayesian
equivalents are still in their infancy [50].
4.3 Efficient inference
The other key challenge area is that of computationally efficient statistical in-
ference. This is of particular importance in the context of epidemic modelling,
not only as a way of addressing the complexity inherent in a realistic model of
a stochastic process informed by multiple data sources, but also because real-
time estimation is crucial for addressing public health policy needs in the midst
of an emerging epidemic [16]. Much progress has been made in developing and
applying efficient algorithms for epidemic evidence syntheses, such as: sequential
Bayesian methods [47, 8], including likelihood-free particle MCMC [43]; approxi-
mate Bayesian computation [44]. Alternatively, to achieve efficient inference, one
might approximate the complex epidemic model with a readily implementable
proxy. Shaman and colleagues have produced a number of papers [e.g. 46, see
also [51] for an application to global measles data] that use an extended Kalman
filter (EKF) to provide a stochastic time series approximation to the dynamics of
SIR models, whereas Bayesian emulation [22] seeks to characterise an epidemic
model (or simulator) with an emulator, built from a dynamic Gaussian process
prior. The next challenge is to broaden the scope of such algorithms to handle
multiple datasets, possibly diverse in nature.
4.4 Conclusions
A recent review of infectious disease modelling [31] suggests that the full po-
tential of mechanistic models that “simultaneously link data from diverse, het-
erogeneous data sources” has yet to be reached. This is certainly true for fully
stochastic transmission models, though rare examples do exist [44, 48] of such
models embedded within an evidence synthesis. Such rarity and the challenges
discussed above motivate the need for further development in this area. Phylo-
dynamic modelling, in particular, offers a very natural application, relying as it
does upon very different types of data. Here, approaches to propagating the un-
certainty in the ascertainment of phylogenies into models for transmission, and to
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handling multiple exposures and the presence of within-host phenotypic variation
all present significant methodological challenges.
However, the many examples reviewed in Section 3, particularly for determin-
istic models, suggest that evidence synthesis for mechanistic models is both a
well-established and rapidly expanding field.
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